Ongoing Phase 3 trials are registered on ClinicalTrials.gov
The study tested several dose levels: 1 mg, 4 mg, 8 mg, and 12 mg
If hunger has returned, the patient may need satiety-focused nutrition, meal timing, fiber, and a realistic plan for cravings
If this condition is left untreated, gastroparesis could contribute to malnutrition, dehydration, the formation of a bezoar (a solid mass in the stomach), and a host of other health problems
In some cases, things are more severe
Newer oral GLP-1 options like the Wegovy pill are more affordable currently around $149 per month but clinical trials show they deliver somewhat less weight loss than injectables, averaging around 1516% compared to 20% or more with injections. For patients who need significant weight loss to resolve health conditions, a lower-cost medication that produces fewer results may not be enough